The Immortal Dragons is a venture capital fund focused on life extension and longevity biotechnology. It is headquartered at Biopolis in Singapore.
History Immortal Dragons was founded by Boyang Wang.https://www.technologynetworks.com/tn/editor/boyang-wang He launched the fund with US$40 million in assets under management. The fund invests in early-stage startups focused on experimental life-extension technologies, such as xenotransplantation, 3D bioprinting, gene therapy, artificial womb.
As of 2026, it has invested in California-based regenerative medicine startup R3 Bio, 3D bioprinting company Frontier Bio, and Unlimited Bio, which develops combinatorial anti-aging therapies. The fund also supports longevity outreach and education, including translations and publication of longevity-related books, a Chinese-language longevity podcast, and sponsorship of conferences and initiatives such as Vitalist Bay and ARDD 2025.
References